• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by Agape ATP Corporation

    3/31/26 4:20:28 PM ET
    $ATPC
    Medical/Nursing Services
    Health Care
    Get the next $ATPC alert in real time by email
    NT 10-K 1 formnt10-k.htm NT 10-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 12b-25

     

     

     

    NOTIFICATION OF LATE FILING

     

    (Check One):  

    ☒ Form 10-K     ☐ Form 20-F      ☐ Form 11-K     ☐ Form 10-Q

    ☐ Form 10-D     ☐ Form N-CEN ☐ Form N-CSR

         
        For Period Ended: December 31, 2025
         
        ☐ Transition Report on Form 10-K
         
        ☐ Transition Report on Form 20-F
         
        ☐ Transition Report on Form 11-K
         
        ☐ Transition Report on Form 10-K
         
        For the Transition Period Ended: _____________

     

    Read Instructions (on back page) Before Preparing Form. Please Print or Type.
    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I — REGISTRANT INFORMATION

     

    Full Name of Registrant:   Agape ATP Corporation
    Former Name if Applicable:   N/A

    Address of Principal Executive Office

    (Street and Number):

      1705 - 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia, Taman Desa,
    City, State and Zip Code:   Kuala Lumpur, Malaysia 58100

     

     

     

     
     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

     

      (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         
    ☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
         
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III — NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    Agape ATP Corporation (the “Company”) is unable to file its Form 10-K for the year ended December 31, 2025 within the prescribed time period without unreasonable effort or expense because the Company needs additional time to obtain supporting documentation to complete the Form 10K and to permit the Company’s independent registered public accounting firm to complete its audit of the consolidated financial statements included in the Form 10-K for the year ended December 31, 2025. The Company anticipates that it will file its Form 10-K within the fifteen-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

     

    PART IV — OTHER INFORMATION

     

      (1) Name and telephone number of person to contact in regard to this notification:

     

    How Kok Choong   60   192230099
    (Name)   (Area Code)   (Telephone Number)

     

      (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
         
         
         
      (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No  

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     
     

     

    Agape ATP Corporation

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: March 31, 2025 By: /s/ How Kok Choong
        How Kok Choong
        Chief Executive Officer, President, Director, Secretary and Treasurer

     

     

     

    Get the next $ATPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATPC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATPC
    SEC Filings

    View All

    SEC Form NT 10-K filed by Agape ATP Corporation

    NT 10-K - Agape ATP Corp (0001713210) (Filer)

    3/31/26 4:20:28 PM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Agape ATP Corp (0001713210) (Filer)

    3/12/26 9:00:25 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Agape ATP Corp (0001713210) (Filer)

    3/10/26 9:00:39 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    $ATPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATPC Expands Global Market Footprint to Spearhead Medical Innovation with MoUs in Indonesia

    Agreements to drive clinical research, enhance product safety, and combat respiratory diseases KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 29, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), today announced the signing of three Memorandums of Understanding ("MOUs") with prominent healthcare institutions in Indonesia. This initiative aims to advance medical research, introduce innovative treatment strategies and strengthen training programs to address respiratory diseases such as tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). The signing marks a key milestone in ATPC's strategic expansion plans in Indonesia and Southeast Asia.(L-R): Dr. Fernando Cortizo, ED, Prof.

    11/29/24 9:00:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    Agape ATP Corporation - Synergising Innovation Across Business Pillars to Make the World a Better Place

    ATPC Unveils Its Multifaceted Business Pillars to Drive Global Wellness and Sustainability KUALA LUMPUR, MALAYSIA / ACCESSWIRE / October 10, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to present its multifaceted business pillars, each driven by a shared vision to make the world a better place. With a strong commitment to sustainability, health, and enhancing quality of life, ATPC has strategically developed six (6) core pillars that work in synergy to address the world's most pressing challenges, from energy conservation to advanced medical care.ATPC Green Energy ("AGE") spearheads ATPC's efforts in the energy sector, with initiatives aiming to provide sustainable energy s

    10/10/24 9:20:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    ATPC and FORMEDIC Technologies Announce Strategic Collaboration to Launch LEGA, a Revolutionary Respiratory Care Device

    Innovative Collaboration Brings Advanced Respiratory Solutions to a Global Market KUALA LUMPUR, MALAYSIA / ACCESSWIRE / September 30, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"), is proud to announce a strategic collaboration with FORMEDIC Technologies Sdn. Bhd. ("FORMEDIC Technologies") to introduce LEGA, an electronic chest percussion device for respiratory care. This partnership marks a major advancement in respiratory health, as the two companies combine their strengths to address the growing demand for advanced respiratory solutions.LEGA, FORMEDIC's flagship product, assists patients with chronic obstructive pulmonary diseases ("COPD"), pneumonia, bronchiectasis, and other lung-

    9/30/24 11:45:00 PM ET
    $ATPC
    Medical/Nursing Services
    Health Care

    $ATPC
    Leadership Updates

    Live Leadership Updates

    View All

    Agape ATP Corporation Announces US$1 Million Share Repurchase Plan

    KUALA LUMPUR, MALAYSIA / ACCESSWIRE / November 22, 2023 / AGAPE ATP Corporation (NASDAQ:ATPC) ("ATPC" or the "Company") announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase up to US$1 million of its shares over the next 6 months. The board of directors have also approved the appointment of Network 1 Financial Securities as the broker to execute the repurchase on behalf of ATPC.The share repurchases may be made from time to time in the open market transactions, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable secur

    11/22/23 9:00:00 AM ET
    $ATPC
    Medical/Nursing Services
    Health Care